Sign up USA
Proactive Investors - Run By Investors For Investors
Market: TSX
52-week High/Low: C$346.32 / C$24.50
Sector: Health Care, Equipment & Services
Market Cap: C$10,301.20M
Valeant Pharmaceuticals

Valeant Pharmaceuticals

Valeant Pharmaceuticals International Inc., formerly Biovail Corporation, is a Canadian specialty pharmaceutical company engaged in the application of drug-delivery technologies to improve the clinical effectiveness of medicines. Its therapeutic areas of focus are central nervous system (CNS) disorders, pain management and cardiovascular disease (including Type II diabetes).

Valeant Pharmaceuticals

Interactive graph

col 3
col 4
col 5
col 6

Valeant Pharmaceuticals Timeline

Market Reports Including VRX

Copyright ©, 2016. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC